1. Home
  2. CASI vs NMTC Comparison

CASI vs NMTC Comparison

Compare CASI & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • NMTC
  • Stock Information
  • Founded
  • CASI 1991
  • NMTC 2009
  • Country
  • CASI China
  • NMTC United States
  • Employees
  • CASI N/A
  • NMTC N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • NMTC Medical/Dental Instruments
  • Sector
  • CASI Health Care
  • NMTC Health Care
  • Exchange
  • CASI Nasdaq
  • NMTC Nasdaq
  • Market Cap
  • CASI 31.0M
  • NMTC 30.9M
  • IPO Year
  • CASI 1996
  • NMTC N/A
  • Fundamental
  • Price
  • CASI $1.89
  • NMTC $0.62
  • Analyst Decision
  • CASI Strong Buy
  • NMTC Strong Buy
  • Analyst Count
  • CASI 1
  • NMTC 1
  • Target Price
  • CASI $4.00
  • NMTC $1.45
  • AVG Volume (30 Days)
  • CASI 8.4K
  • NMTC 358.3K
  • Earning Date
  • CASI 05-20-2025
  • NMTC 05-13-2025
  • Dividend Yield
  • CASI N/A
  • NMTC N/A
  • EPS Growth
  • CASI N/A
  • NMTC N/A
  • EPS
  • CASI N/A
  • NMTC N/A
  • Revenue
  • CASI $28,537,000.00
  • NMTC $5,749,521.00
  • Revenue This Year
  • CASI N/A
  • NMTC $292.88
  • Revenue Next Year
  • CASI N/A
  • NMTC N/A
  • P/E Ratio
  • CASI N/A
  • NMTC N/A
  • Revenue Growth
  • CASI N/A
  • NMTC 104.21
  • 52 Week Low
  • CASI $1.64
  • NMTC $0.40
  • 52 Week High
  • CASI $7.67
  • NMTC $1.39
  • Technical
  • Relative Strength Index (RSI)
  • CASI 44.54
  • NMTC 44.26
  • Support Level
  • CASI $1.64
  • NMTC $0.60
  • Resistance Level
  • CASI $1.94
  • NMTC $0.66
  • Average True Range (ATR)
  • CASI 0.09
  • NMTC 0.05
  • MACD
  • CASI -0.00
  • NMTC 0.02
  • Stochastic Oscillator
  • CASI 55.77
  • NMTC 40.10

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

Share on Social Networks: